Welcome to the summer edition of Hudson News. It is my great pleasure and honour to write to you in my new role as the Director and CEO of Hudson Institute of Medical Research.
Run Melbourne success
In July, more than 50 of our scientists, staff and students ran or walked in the Run Melbourne event to raise funds for new equipment.
Pancreatic cancer clinical trial aims to improve survival rates
Pancreatic cancer has one of the lowest survival rates of any major cancer. Sadly, the statistics have not changed significantly over the last 40 years.
Dr Simon Chu
"My research examines the role of female reproductive hormones in ovarian granulosa cell tumours, a subtype of ovarian tumours affecting two to five per cent of patients. My work is aimed at finding new treatments to prevent the growth and spread of these tumours."
Miracle regenerative tissue provides hope
Solutions for women’s reproductive health conditions including endometriosis and endometrial cancer will be accelerated thanks to a discovery by Professor Caroline Gargett’s team in The Ritchie Centre.
Hudson Institute joins international paediatric cancer consortium
Hudson Institute scientists will share expertise with leading international research institutions to progress research and improve treatments for children and adolescents with brain cancer.